AstraZeneca, SWIBCo Launch Stem Cell Cardiovascular Therapy Collaboration – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
AstraZeneca, SWIBCo Launch Stem Cell Cardiovascular Therapy Collaboration
Genetic Engineering & Biotechnology News AstraZeneca will develop novel cardiovascular and catheter-based therapies using Procella Therapeutics' stem cell technology and Smartwise's catheter injection method, it was disclosed today, through a collaboration that could generate up to $320 … |
